• Lypressin Acetate: Mechanistic Insight and Translational Str

  2026-04-24

  This thought-leadership article explores the mechanistic underpinnings and strategic potential of Lypressin acetate in translational research. By integrating evidence from peer-reviewed literature and cross-domain applications, it provides actionable guidance for researchers in endocrine, cardiovascular, and emerging antiviral fields. The piece uniquely bridges mechanistic pharmacology with translational context, outperforming standard product summaries by offering protocol guidance, competitive analysis, and an informed outlook.

• METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC

  2026-04-24

  Wang et al. (2024) uncover a METTL16-driven signaling axis that confers ferroptosis resistance and accelerates tumorigenesis in hepatocellular carcinoma (HCC). Their mechanistic work reveals new intervention targets for sensitizing HCC cells to ferroptosis, with translational implications for cancer research.

• E3 Gene Deletion Does Not Attenuate CAdV-2 Pathogenicity in

  2026-04-23

  This study characterized a novel canine adenovirus type 2 (CAdV-2) strain with a 9-nucleotide E3 gene deletion and compared its pathogenicity to wild-type isolates in experimental canine infections. Results revealed that the E3-deleted strain retained virulence, indicating functional redundancy in the E3 region and informing ongoing vaccine and surveillance strategies.

• MDL 28170: Precision Calpain Inhibition for Translational Im

  2026-04-23

  This thought-leadership article provides mechanistic and strategic insights into the use of MDL 28170, a selective calpain and cathepsin B inhibitor, for translational researchers tackling neuroprotection, ischemia-reperfusion injury, and beyond. Drawing on pivotal evidence, including recent Neuropharmacology findings on BDNF/TrkB signaling disruption, the piece offers actionable protocol guidance and competitive context. It advances the discourse by bridging rigorous mechanistic rationale with practical workflow recommendations, elevating the conversation beyond standard product summaries.

• Halazone: Antimicrobial Sulfonamide Derivative in Water and

  2026-04-22

  Halazone stands out as a dual-function antimicrobial sulfonamide derivative: a gold-standard water disinfection agent and a precise modulator of neuronal sodium channels in electrophysiology. This article delivers protocol-level guidance and troubleshooting tips for both microbiological and neurophysiological research, leveraging Halazone’s unique oxidative and membrane-modifying actions.

• Plant Exosome-like Nanovesicles Restore Sertoli Cell Functio

  2026-04-22

  This study reveals that exosome-like nanovesicles derived from Cistanche deserticola (CDELNs) significantly alleviate cyclophosphamide-induced testicular injury by targeting cell cycle arrest in Sertoli cells. The work uncovers a novel, HSPG-mediated uptake mechanism and miRNA-driven pathway modulation, providing a foundation for innovative therapeutic strategies in male reproductive toxicity.

• Ruxolitinib Induces Apoptosis and Pyroptosis in ATC via DRP1

  2026-04-21

  This study demonstrates that Ruxolitinib phosphate (INCB018424), a selective JAK1/JAK2 inhibitor, triggers apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) by suppressing DRP1-mediated mitochondrial fission through transcriptional inhibition. The findings highlight a novel link between JAK/STAT pathway modulation and mitochondrial dynamics, providing a mechanistic rationale for targeting JAK1/2-STAT3 in aggressive thyroid cancers.

• Amyloid Beta-peptide (25-35): Applied Workflows in Neurotoxi

  2026-04-21

  Amyloid Beta-peptide (25-35) (Aβ25-35) empowers researchers with a reproducible and mechanistically relevant model for investigating Alzheimer's disease neurotoxicity and microglial activation. This article delivers stepwise workflow enhancements, troubleshooting guidance, and actionable insights from recent reference studies—enabling confident deployment of Aβ25-35 for neurodegenerative disease research.

• Distinguishing Growth Inhibition and Cell Death in Cancer Dr

  2026-04-20

  Schwartz’s dissertation establishes rigorous in vitro methodologies to disentangle proliferative arrest from cell death in cancer drug evaluation. This nuanced approach enables more precise assessment of anti-cancer compounds, informing both mechanistic studies and preclinical screening.

• Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work

  2026-04-20

  Cy5 NHS ester(Et) provides a high-purity, water-soluble solution for direct fluorescent labeling of amino groups in proteins and biomolecules, supporting robust detection in immunofluorescence, flow cytometry, and fluorescence microscopy. This reagent is not suitable for ethanol-based protocols or for workflows requiring extended storage of dye solutions, making it optimal for immediate-use applications.

• ARCA EGFP mRNA (5-moUTP): Superior Polyadenylated mRNA for R

  2026-04-19

  ARCA EGFP mRNA (5-moUTP) sets the standard for robust, immune-silent, and highly quantifiable fluorescence-based transfection controls in mammalian cells. Leveraging advanced cap and nucleotide modifications, this polyadenylated mRNA optimizes both stability and protein expression—empowering both routine and high-throughput assays with unprecedented reproducibility.

• Vitamin K2 Counteracts Osteoblast Ferroptosis in GIOP via NR

  2026-04-18

  This study demonstrates that vitamin K2 protects against glucocorticoid-induced osteoporosis by activating the NRF2/FSP1 pathway, thereby inhibiting ferroptosis in osteoblasts and preserving bone mass. These findings advance mechanistic understanding of oxidative stress in bone disease and highlight ferroptosis inhibition as a promising therapeutic direction.

• Vincristine Sulfate (A1765): Mechanisms & Applications in Ca

  2026-04-17

  Vincristine sulfate is a validated microtubule disrupter with well-characterized anti-proliferative effects in cancer research. APExBIO’s A1765 product provides high solubility and reproducibility for in vitro and in vivo workflows. This dossier details its mechanisms, benchmarks, and limitations for oncology studies.

• Cisplatin (CDDP): Mechanisms and Benchmarks in Cancer Resear

  2026-04-16

  Cisplatin (CDDP) is a gold-standard DNA crosslinking agent for cancer research, inducing apoptosis via DNA damage and ROS-mediated pathways. Its robust anticancer activity is central to apoptosis assays and tumor xenograft inhibition studies. This article details its biological rationale, protocols, limits, and integration in modern workflows, with evidence-backed best practices.

• Sulfo-NHS-SS-Biotin: Precision Cell Surface Protein Labeling

  2026-04-15

  Sulfo-NHS-SS-Biotin enables selective, high-specificity labeling of cell surface proteins with a cleavable design ideal for reversible affinity purification and dynamic interactome mapping. Discover how this biotin disulfide N-hydroxysulfosuccinimide ester streamlines workflows in protein purification and cell biology, with expert troubleshooting and protocol optimization tips.

16581 records 1/1106 page Next 12345 下5页 Last page